Correction of Nasolabial Folds Clinical Trial
Official title:
A Post-market, Prospective, Observational (Non-interventional), Partly Confirmatory, Multi-centre Clinical Investigation to Confirm the Clinical Safety and Performance Profile of Decoria® Intense Hyaluronic Acid Dermal Filler for the Correction of Nasolabial Folds.
Decoria intense is a class III medical device and is CE-marked and has been on the market since 2014. Decoria intense is a hyaluronic acid filler that will be used according to intended use for correction of nasolabial folds. According to the new MDR in EU this clinical investigation will confirm efficacy and safety of Decoria intense. The plan is to recruit 80 subjects to receive 64 evaluable subjects during 6 months recruitment. The clinical investigation contains 5 visits and the total time per subject is 12 months. All subjects will receive treatment at Visit 1 with the option to receive a touch-up treatment at Visit 2. Evaluation of the nasolabial folds will be performed by PI using the Wrinkle Severity Rating Scale (WSRS)
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02334358 -
Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s
|
||
Completed |
NCT03611491 -
Post Market Study Evaluating Princess Filler Lidocaine for the Correction of Nasolabial Folds
|
N/A | |
Completed |
NCT05106751 -
A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Investigation to Evaluate the Performance and Safety of YVOIRE® Classic Plus Versus Comparator for Temporary Correction of Nasolabial Folds
|
Phase 4 | |
Completed |
NCT02661737 -
Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volume s
|
||
Completed |
NCT02179606 -
Clinical Study to Evaluate the Efficacy and Safety of Dermalax Implant Plus
|
Phase 3 | |
Completed |
NCT03650218 -
Safety and Effectiveness of THIODERM STRONG in the Correction of Nasolabial Folds
|
N/A | |
Completed |
NCT02179619 -
Clinical Study to Evaluate the Efficacy and Safety of Dermalax(Deep) in Correction of Nasolabial Folds
|
Phase 3 | |
Unknown status |
NCT01492140 -
Injection Assistance Device Versus Manual Injections for Delivery of Dermal Fillers
|
Phase 4 |